BioSpace News Archive

Acquisition expands endoscopic portfolio to include radiofrequency devices.

Serametrix flow cytometry and related data analysis services are already widely used in immunotherapy drug trials.

Rare Pediatric Disease Designation granted for the treatment of patients with necrotizing enterocolitis (NEC),

Advanced technologies help healthcare providers and payers to reduce claims denials, increase claims processing transparency and improve collection of patient financial responsibilities.

Bristol-Myers Squibb Company (NYSE:BMY) will participate in the Cowen and Company 38th Annual Global Health Care Conference on Monday, March 12, 2018, in Boston.

Conference call scheduled today at 9:00 a.m. ET

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today announced that Gaurav Shah, M.D., Chief Executive Officer and President of Rocket, will present at the Cowen & Company 38th Annual Health Care Conference on Monday, March 12th, 2018, at 2:50 p.m. Eastern Time (ET).

MRI results show increases in pelvic floor muscle and urethral muscle diameter supporting enobosarm’s mechanism of action.

SpringWorks Therapeutics, a mission-driven medicines company dedicated to developing innovative potential new treatments for underserved patient communities, today announced that the Company will present at the Cowen and Company 38th Annual Health Care Conference.

This agreement follows the first agreement between the two parties signed in June 2017, for the validation of MyBiotics’ technology in the treatment of a non-disclosed gastroenterology condition.